Today: 17 December 2025
Subscribe
Browse Tag

financial guidance

Pagaya Technologies (PGY) posts record Q3 2025, raises full‑year guidance to $1.30–$1.325B; shares climb in early trade — Nov. 10, 2025

Pagaya Technologies (PGY) posts record Q3 2025, raises full‑year guidance to $1.30–$1.325B; shares climb in early trade — Nov. 10, 2025

Pagaya Technologies Ltd. reported record third‑quarter results and lifted its 2025 outlook before today’s earnings call, citing broad‑based growth across personal loans, auto, and point‑of‑sale financing. The company also outlined a stronger funding posture heading into year‑end. Business Wire Key
10 November 2025
 ·  ·  ·  · 
Iovance Biotherapeutics (IOVA) Q3 2025: Revenue Climbs ~13% to ~$68M; Gross Margin Hits 43%, Guidance Reaffirmed — November 6, 2025

Iovance Biotherapeutics (IOVA) Q3 2025: Revenue Climbs ~13% to ~$68M; Gross Margin Hits 43%, Guidance Reaffirmed — November 6, 2025

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) reported third‑quarter 2025 results this morning (Nov. 6), highlighting sequential revenue growth, materially higher gross margins, and steady commercial momentum for its tumor‑infiltrating lymphocyte (TIL) therapy Amtagvi. Management also reaffirmed full‑year revenue guidance and flagged
6 November 2025
 ·  ·  ·  ·  · 
DoorDash’s DOT: The Little Robot That Could – Is Suburban Delivery About to Be Revolutionized?

DASH Stock Today (Nov. 5, 2025): DoorDash Slides After Q3 EPS Miss Despite Strong Sales; Bold 2026 Spend and Big Q4 GMV Guidance

Dateline: November 5, 2025 — DoorDash (NASDAQ: DASH) fell in late trading after its third‑quarter report delivered a classic “beat and miss”: revenue topped expectations while earnings per share came in below consensus. Management also telegraphed “several hundred million” dollars
5 November 2025
 ·  ·  ·  ·  · 
Go toTop